The Global Vaccine Gap

Prognosis: Losing it - A podcast by Bloomberg

In a race to catch up with emerging coronavirus variants, wealthy countries are already benefiting from potent vaccines. While the U.S., Britain and European Union have given citizens about 24 million doses so far -- more than half of the shots administered globally -- vast numbers of countries have yet to begin their campaigns. James Paton reports that these disparities pose a threat to both have and have-not states.See omnystudio.com/listener for privacy information.